Literature DB >> 22388999

Delayed dislocation of a sutureless aortic bioprosthesis: the first case.

Giovanni Concistrè1, Antonio Miceli, Francesca Chiaramonti, Mattia Glauber.   

Abstract

Sutureless aortic bioprosthesis implantation is an alternative technique in high-risk patients undergoing aortic valve replacement with a possible reduction in the extracorporeal circuit time and reliable haemodynamic features. A 3F Enable (ATS Medical-Medtronic, Inc., Minneapolis, MN, USA) has shown very good results. We report the first upward displacement of 3F Enable three months post implantation.

Entities:  

Mesh:

Year:  2012        PMID: 22388999      PMCID: PMC3352697          DOI: 10.1093/icvts/ivr015

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  [Early single-center experience with the 3F-enable aortic valve bioprosthesis].

Authors:  Rainer Leyh; Chagatay Yildirim; Thomas Buck; Sebastian Sommer; Ulf Herold; Heinz Jakob
Journal:  Herz       Date:  2006-08       Impact factor: 1.443

2.  Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis.

Authors:  Sven Martens; Anja Ploss; Sami Sirat; Alexandra Miskovic; Anton Moritz; Mirko Doss
Journal:  Ann Thorac Surg       Date:  2009-06       Impact factor: 4.330

3.  Transapical minimally invasive aortic valve implantation: multicenter experience.

Authors:  Thomas Walther; Paul Simon; Todd Dewey; Gerhard Wimmer-Greinecker; Volkmar Falk; Marie T Kasimir; Mirko Doss; Michael A Borger; Gerhard Schuler; Dietmar Glogar; Wolfgang Fehske; Ernst Wolner; Friedrich W Mohr; Michael Mack
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

Review 4.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Chatterjee Kanu; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-08-01       Impact factor: 29.690

5.  First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis.

Authors:  Daniel Wendt; Matthias Thielmann; Thomas Buck; Rolf-Alexander Jánosi; Torsten Bossert; Nikolaus Pizanis; Markus Kamler; Heinz Jakob
Journal:  Eur J Cardiothorac Surg       Date:  2008-02-05       Impact factor: 4.191

  5 in total
  3 in total

1.  Sutureless aortic bioprosthesis in severe aortic root calcification: an innovative approach.

Authors:  Giovanni Concistrè; Pierandrea Farneti; Antonio Miceli; Mattia Glauber
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-20

Review 2.  Advances in the management of severe aortic stenosis.

Authors:  K E O'Sullivan; S Bargenda; D Sugrue; J Hurley
Journal:  Ir J Med Sci       Date:  2016-02-17       Impact factor: 1.568

3.  Mid-term follow-up after suture-less aortic heart valve implantation.

Authors:  Grzegorz Filip; Radoslaw Litwinowicz; Boguslaw Kapelak; Jacek Piatek; Magdalena Bartus; Janusz Konstanty-Kalandyk; Maciej Brzezinski; Krzysztof Bartus
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.